Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 18, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 8 June 2026 - 15:52

Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 18, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/alecensa

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters